Ann: GMP Production of PAT-DX1 Next Quarter, page-12

I don't think any points are being missed. There is just nothing new here, other than the CDMO company who stuffed up the initial manufacturing run resulting in the company losing many months and millions of dollars being able to fit us back into their busy schedule and do another run Q1 2024, which we all expected.

Until this repeat manufacturing run goes to plan and we can be relatively confident we will actually make it to trials, then this means zilch. This has been the hurdle which has plagued the company for years. Until it is confirmed that DX1 can be manufactured at scale, it is worthless.